Gain-of-function variants in the ODC1 gene cause a syndromic neurodevelopmental disorder associated with macrocephaly, alopecia, dysmorphic features, and neuroimaging abnormalities.

Am J Med Genet A 2018 12 26;176(12):2554-2560. Epub 2018 Nov 26.

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Polyamines serve a number of vital functions in humans, including regulation of cellular proliferation, intracellular signaling, and modulation of ion channels. Ornithine decarboxylase 1 (ODC1) is the rate-limiting enzyme in endogenous polyamine synthesis. In this report, we present four patients with a distinct neurometabolic disorder associated with de novo heterozygous, gain-of-function variants in the ODC1 gene. This disorder presents with global developmental delay, ectodermal abnormalities including alopecia, absolute or relative macrocephaly, and characteristic facial dysmorphisms. Neuroimaging variably demonstrates white matter abnormalities, prominent Virchow-Robin spaces, periventricular cysts, and abnormalities of the corpus callosum. Plasma clinical metabolomics analysis demonstrates elevation of N-acetylputrescine, the acetylated form of putrescine, with otherwise normal polyamine levels. Therapies aimed at reducing putrescine levels, including ODC1 inhibitors, dietary interventions, and antibiotics to reduce polyamine production by gastrointestinal flora could be considered as disease-modifying therapies. As the ODC1 gene has been implicated in neoplasia, cancer surveillance may be important in this disorder.

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajmg.a.60677
Publisher Site
http://dx.doi.org/10.1002/ajmg.a.60677DOI Listing
December 2018
28 Reads

Publication Analysis

Top Keywords

odc1 gene
12
gain-of-function variants
8
variants odc1
8
disorder associated
8
odc1
5
developmental delay
4
reducing putrescine
4
putrescine levels
4
levels including
4
presents global
4
delay ectodermal
4
global developmental
4
including alopecia
4
absolute relative
4
relative macrocephaly
4
aimed reducing
4
alopecia absolute
4
abnormalities including
4
including odc1
4
ectodermal abnormalities
4

References

(Supplied by CrossRef)
DFMO: Targeted risk reduction for colorectral neoplasia
Laukaitis et al.
Best Practice & Research. Clinical Gastroenterology 2012
Regulation of polyamine metabolism by Curcumin for cancer prevention and therapy
Murray-Stewart et al.
Medical Science 2017

Similar Publications